Sonder Holdings Inc. (SOND)
NASDAQ: SOND · Real-Time Price · USD
2.120
-0.060 (-2.75%)
At close: Aug 1, 2025, 4:00 PM
2.070
-0.050 (-2.36%)
After-hours: Aug 1, 2025, 4:11 PM EDT
CTI BioPharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for CTI BioPharma.
Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for CTI BioPharma.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $23 → $4 | Strong Buy → Hold | Downgrades | $23 → $4 | +88.68% | Dec 20, 2023 |
| Citigroup | Citigroup | Strong Buy Maintains $30 → $23 | Strong Buy | Maintains | $30 → $23 | +984.91% | Aug 11, 2023 |
| Citigroup | Citigroup | Strong Buy Maintains $40 → $30 | Strong Buy | Maintains | $40 → $30 | +1,315.09% | Jul 17, 2023 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 30, 2023 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 22, 2023 |
Financial Forecast
Revenue This Year
909.97M
from 621.27M
Increased by 46.47%
Revenue Next Year
n/a
from 909.97M
EPS This Year
-6.83
from -20.69
EPS Next Year
n/a
from -6.83
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 |
|---|---|
| High | 971.5M |
| Avg | 910.0M |
| Low | 841.8M |
Revenue Growth
| Revenue Growth | 2025 |
|---|---|
| High | 56.4% |
| Avg | 46.5% |
| Low | 35.5% |
EPS Forecast
| EPS | 2025 |
|---|---|
| High | -7.04 |
| Avg | -6.83 |
| Low | -6.57 |
EPS Growth
| EPS Growth | 2025 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.